BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 26304699)

  • 1. Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.
    Fraga-Silva RA; Montecucco F; Costa-Fraga FP; Nencioni A; Caffa I; Bragina ME; Mach F; Raizada MK; Santos RAS; da Silva RF; Stergiopulos N
    Vascul Pharmacol; 2015 Nov; 74():103-113. PubMed ID: 26304699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques.
    Fraga-Silva RA; Savergnini SQ; Montecucco F; Nencioni A; Caffa I; Soncini D; Costa-Fraga FP; De Sousa FB; Sinisterra RD; Capettini LA; Lenglet S; Galan K; Pelli G; Bertolotto M; Pende A; Spinella G; Pane B; Dallegri F; Palombo D; Mach F; Stergiopulos N; Santos RA; da Silva RF
    Thromb Haemost; 2014 Apr; 111(4):736-47. PubMed ID: 24499778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis.
    Stachowicz A; Wiśniewska A; Kuś K; Białas M; Łomnicka M; Totoń-Żurańska J; Kiepura A; Stachyra K; Suski M; Bujak-Giżycka B; Jawień J; Olszanecki R
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury.
    Fraga-Silva RA; Costa-Fraga FP; Montecucco F; Sturny M; Faye Y; Mach F; Pelli G; Shenoy V; da Silva RF; Raizada MK; Santos RA; Stergiopulos N
    J Sex Med; 2015 Feb; 12(2):289-302. PubMed ID: 25411084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apelin-13 treatment enhances the stability of atherosclerotic plaques.
    Fraga-Silva RA; Seeman H; Montecucco F; da Silva AR; Burger F; Costa-Fraga FP; Anguenot L; Mach F; Dos Santos RAS; Stergiopulos N; da Silva RF
    Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29336478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response.
    Zhang YH; Zhang YH; Dong XF; Hao QQ; Zhou XM; Yu QT; Li SY; Chen X; Tengbeh AF; Dong B; Zhang Y
    Inflamm Res; 2015 Apr; 64(3-4):253-60. PubMed ID: 25721616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques.
    Wu H; Cheng XW; Hu L; Hao CN; Hayashi M; Takeshita K; Hamrah MS; Shi GP; Kuzuya M; Murohara T
    Atherosclerosis; 2014 Dec; 237(2):739-47. PubMed ID: 25463114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
    Shami A; Gustafsson R; Kalamajski S; Krams R; Segers D; Rauch U; Roos G; Nilsson J; Oldberg Å; Hultgårdh-Nilsson A
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):354-61. PubMed ID: 23202368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice.
    Nencioni A; da Silva RF; Fraga-Silva RA; Steffens S; Fabre M; Bauer I; Caffa I; Magnone M; Sociali G; Quercioli A; Pelli G; Lenglet S; Galan K; Burger F; Vázquez Calvo S; Bertolotto M; Bruzzone S; Ballestrero A; Patrone F; Dallegri F; Santos RA; Stergiopulos N; Mach F; Vuilleumier N; Montecucco F
    Thromb Haemost; 2014 Feb; 111(2):308-22. PubMed ID: 24196571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous activated angiotensin-(1-7) plays a protective effect against atherosclerotic plaques unstability in high fat diet fed ApoE knockout mice.
    Yang J; Yang X; Meng X; Dong M; Guo T; Kong J; Zhang K; Zhang Y; Zhang C
    Int J Cardiol; 2015 Apr; 184():645-652. PubMed ID: 25771230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
    Selle J; Asare Y; Köhncke J; Alampour-Rajabi S; Shagdarsuren G; Klos A; Weber C; Jankowski J; Shagdarsuren E
    Thromb Haemost; 2015 Oct; 114(4):848-58. PubMed ID: 26084965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.
    Yang JM; Dong M; Meng X; Zhao YX; Yang XY; Liu XL; Hao PP; Li JJ; Wang XP; Zhang K; Gao F; Zhao XQ; Zhang MX; Zhang Y; Zhang C
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1978-85. PubMed ID: 23723368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase inhibition prevents the low shear stress-induced development of vulnerable atherosclerotic plaques in ApoE-/- mice.
    Olivon VC; Fraga-Silva RA; Segers D; Demougeot C; de Oliveira AM; Savergnini SS; Berthelot A; de Crom R; Krams R; Stergiopulos N; da Silva RF
    Atherosclerosis; 2013 Apr; 227(2):236-43. PubMed ID: 23390893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques.
    Harmon EY; Fronhofer V; Keller RS; Feustel PJ; Zhu X; Xu H; Avram D; Jones DM; Nagarajan S; Lennartz MR
    J Am Heart Assoc; 2014 Dec; 3(6):e001232. PubMed ID: 25516435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice.
    Wang L; Wang W; Shah PK; Song L; Yang M; Sharifi BG
    Cardiovasc Pathol; 2012; 21(5):398-413. PubMed ID: 22300502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
    Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
    J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice.
    Li G; Wu XW; Lu WH; Ai R; Chen F; Tang ZZ
    BMC Cardiovasc Disord; 2014 Oct; 14():145. PubMed ID: 25326709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.